Paper Details

  1. Home
  2. Paper Details

Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age.

Author: BoisnardFlorence, MwawasiGrace, ReynoldsDonna, SilfverdalSven Arne, ThomasStéphane, VesikariTimo

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

DTaP(5)-IPV-Hib, a fully liquid combination vaccine, demonstrated noninferiority to DTaP(3)-IPV/Hib for diphtheria, tetanus, and polio seroprotection in infants. Safety profiles were generally comparable between the two vaccines.
Paper Details　
Original Abstract of the Article :
This study compared the levels of immunogenicity and safety of diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP(5)), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) (DTaP(5)-IPV-Hib) and DTaP(3)-IPV/Hib vaccines for study participants 3, 5, and 12 months of ag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807208/

データ提供：米国国立医学図書館（NLM）

DTaP5-IPV-Hib Vaccine: A Comparison of Immunogenicity and Safety

This study delves into the world of [vaccinations], comparing the immunogenicity and safety of two different [combination vaccines] for infants aged [3, 5, and 12 months]. The researchers tested the [DTaP(5)-IPV-Hib] and [DTaP(3)-IPV/Hib] vaccines to determine their effectiveness in stimulating an immune response against various diseases.

Think of it like training a herd of camels to protect themselves from different threats. Some camels (DTaP(5)-IPV-Hib) receive a more comprehensive training program covering a wider range of dangers, while others (DTaP(3)-IPV/Hib) focus on a specific set of threats. This study investigates which training approach produces the best results.

A Robust Immune Response

The study found that both vaccines provided [effective protection] against [diphtheria, tetanus, and polio types 1 to 3]. While the [DTaP(5)-IPV-Hib] vaccine did not meet the noninferiority criteria for [PRP], it still demonstrated a [clinically robust immune response]. This indicates that both vaccines can effectively equip infants with the necessary defenses against these common childhood illnesses.

Safe and Effective Vaccinations

This study offers valuable insights into the safety and efficacy of different [combination vaccines]. It provides evidence that the [DTaP(5)-IPV-Hib] vaccine is a safe and effective option for infants following the [3-, 5-, and 12-month vaccination schedule]. These findings are a reminder of the importance of [vaccinations] in protecting children from serious diseases. Just as a camel caravan relies on its members being protected from dangers, a healthy society needs strong immunizations to safeguard its citizens.

Dr.Camel's Conclusion

This study underscores the vital role of [vaccinations] in safeguarding children's health. It highlights the effectiveness and safety of [DTaP(5)-IPV-Hib] as an alternative option for infants, ensuring their robust immune system and protecting them from common childhood diseases. Like a camel caravan journeying across the vast desert, a well-vaccinated community is better equipped to overcome challenges and thrive.

Date :
  1. Date Completed 2014-04-21
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23966556

DOI: Digital Object Identifier

PMC3807208

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.